Patenting Stem Cells of Human Origin

dc.contributor.author	Laurie, Graeme	en
dc.date.accessioned	2008-08-18T10:35:35Z
dc.date.available	2008-08-18T10:35:35Z
dc.date.issued	2004
dc.identifier.citation	(2004) European Intellectual Property Review 59-66
dc.identifier.uri	http://hdl.handle.net/1842/2442
dc.description.abstract	The author discusses the impact of the European Union's Directive for the legal protection of biotechnological inventions (Directive 98/44/EC of 6 July 1998. Specific attention is given to the absence from provisions of the mention of human stem cells, which generated significant ethical and legal debate in the UK, and globally, at that time. The paper considers the robustness of European patent provisions, and focusses on the potential consequences in the continuing debate of human stem cells.	en
dc.format.extent	47052 bytes	en
dc.format.mimetype	application/pdf	en
dc.language.iso	en
dc.publisher	AHRC Research Centre for Studies in Intellectual Property and Technology Law	en
dc.subject	embryonic stem cell	en
dc.subject	patent law	en
dc.subject	ethics	en
dc.subject	human stem cells	en
dc.title	Patenting Stem Cells of Human Origin	en
dc.type	Article	en